Preclinical Partnerships

Media Coverage
Scientists at work in lab

Contract Pharma

Preclinical CROs are playing an increasingly vital role in helping to advance drug targets from the discovery phase into development. Partnerships with pharma and biopharma are growing and evolving as sponsors seek out the latest science, drug research technologies, and specialty services.

As an example of partnerships becoming more comprehensive, Charles River recently entered a strategic collaboration with Nimbus Therapeutics aimed at advancing new programs in immunology, metabolic disorders and oncology from the discovery phase through to Investigational New Drug (IND) submission.

Read the full article